American adults have very low rate of metabolic health
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, November 28, 2018–A new study found that the prevalence of metabolic health is very low among American adults, even among those who have normal weight. This has serious implications for public health, according to the study published in Metabolic Syndrome and Related Disorders, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here to read the full-text article free on the Metabolic Syndrome and Related Disorders website through December 28, 2018.
Researchers Joana Araújo, PhD, Jianwen Cai, PhD, and June Stevens, PhD, from University of North Carolina at Chapel Hill, Gillings School of Global Public Health, coauthored the study entitled “Prevalence of Optimal Metabolic Health in American Adults: National Health and Nutrition Examination Survey 2009-2016.”
The researchers used data from the National Health and Nutrition Examination Survey, collected from 2009-2016. They estimated the proportion of American adults who had optimal cardiometabolic health using different sets of guidelines. Compared to older guidelines, the use of more recent guidelines with more rigorous cut-offs saw the proportion of metabolically healthy Americans decreased from near 20% to more than 12%. Optimal metabolic health was based on measures of waist circumference, glucose (fasting and HbA1c), blood pressure, triglyceride and high-density lipoprotein cholesterol levels, and not taking any related medications.
“While we can quibble about the definition of metabolic health, it is alarming that only one-tenth of the population meets criteria for appropriate waist size, glucose, blood pressure and lipid profile” says Dr. Adrian Vella, Editor-in-Chief of Metabolic Syndrome and Related Disorders and Professor, Mayo Clinic College of Medicine, Rochester, MN.
About the Journal
Metabolic Syndrome and Related Disorders is the only peer-reviewed journal to focus solely on the pathophysiology, recognition, and treatment of metabolic syndrome. Led by Adrian Vella, MD, FRCP (Edin.), Professor of Medicine, Endocrinology, Diabetes, Metabolism, and Nutrition, Mayo Clinic College of Medicine, Rochester, MN, the Journal covers a range of topics including insulin resistance, central obesity, glucose intolerance, dyslipidemia with elevated triglycerides, predominance of small dense LDL-cholesterol particles, hypertension, endothelial dysfunction, and oxidative stress and inflammation. Complete tables of content and a sample issue may be viewed on the Metabolic Syndrome and Related Disorders website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Childhood Obesity, Diabetes Technology and Therapeutics, and Thyroid. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Related Journal Article